Abstract
When it comes to prevention and non-invasive treatment, periorbital skin is of particular interest, as it is more sensitive than other areas of the body. A variety of topical options are commonly marketed, causing dilution of evidence and difficulty in selecting optimal treatments. For that reason, it is essential for providers to better understand what compounds show clinically proven efficacy but also what products are readily available. Throughout this chapter, we will first explore the basic mechanisms behind periorbital skin aging and commonly reported patient complaints. Next we will focus on the variety of topical dermatologic treatments, highlighting their mechanism of action and assessing their reported clinical efficacy.
It is often said that the eyes are the windows into the soul, as they convey a form of expression that cannot be put into words. While time passes, and takes its toll on the body and the mind, the eyes remain true to self … ageless.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Datta S, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol. 2004;138(11):1462–70.
Makrantonaki E, Zouboulis CC. Clinical aspects and molecular diagnostics of skin aging. Clin Dermatol. 2011;29(1):3–14.
Shokri T, Lighthall JG. Periorbital rejuvenation. Oper Tech Otolayngol Head Neck Surg. 2018;29(4):243–51.
Glaser DA, Kurta A. Periorbital rejuvenation overview of nonsurgical treatment options. Facial Plast Surg Clin North Am. 2016;24(2):145–52.
Bucay VW, Day D. Adjunctive skin care of the brow and periorbital region. Clin Plast Surg. 2013;40(1):225–36.
Pilkington S, Belden S, Miller RA. The tricky tear trough: a review of topical cosmeceuticals for. J Clin Aesthet Dermatol. 2015;8(9):39–47.
Pratt H, et al. UV imaging reveals facial areas that are prone to skin cancer are disproportionately missed during sunscreen application. PLoS One. 2017;12(10):e0185297.
FDA advances new proposed regulation to make sure that sunscreens are safe and effective. FDA News Release; 2019.
Fisher GJ, et al. Molecular basis of sun-induced premature skin aging and retinoid antagonism. Nature. 1996;379(6563):335–9.
Manaloto RMP, Alster TS. Periorbital rejuvenation: a review of dermatologic treatments. Dermatol Surg. 1999;25(1):1–9.
Fluhr J, Vienne M, Lauze C, Dupuy P, Gehring W, Gloor M. Tolerance profile of retinol, retinaldehyde and retinoic acid under maximized and long-term clinical conditions. Dermatology. 1999;199(Suppl 1):57–60.
Polefka R, Meyer T, Agin T, Bianchini P. Cutaneous oxidative stress. J Cosmet Dermatol. 2012;11(1):55–64.
Al-Niaimi F, Chiang NYZ. Topical vitamin C and the skin: mechanisms of action and clinical applications. J Clin Aesthet Dermatol. 2017;10(7):7–10.
Telang PS. Vitamin C in dermatology. Indian Dermatol. 2013;4(2):143–6.
Keen MA, Hassan I. Vitamin E in dermatology. Indian Dermatol. 2016;7(4):311–5.
Murray JC, Burch JA, Streilein RD, Iannacchione MA, Hall RP, Pinnell SR. A topical antioxidant solution containing vitamins C and E with ferulic acid protects human skin from sunlight damage and DNA mutations associated with skin cancer. J Am Acad Dermatol. 2008;59(3):428–5.
Schagen S. Topical peptide treatments with effective anti-aging results. Cosmetics. 2017;4(2):16.
Wang Y, Wang M, Xiao S, Pan P, Li P, Huo J. The anti-wrinkle efficacy of argireline, a synthetic hexapeptide, in Chinese subjects. Am J Clin Dermatol. 2013;14(2):147–53.
Sundaram H, Gold M, Waldorf H, Lupo M, Nguyen V, Karnik J. Pilot, multicenter, open-label evaluation of safety, tolerability and efficacy of a novel, topical multipotent growth factor formulation for the periorbital region. J Drugs Dermatol. 2015;14(12):1410–7.
Fitzpatrick RE, Rostan EF. Reversal of photodamage with topical growth factors: a pilot study. J Cosmet Laser Ther. 2003;5(1):25–34.
Sarkar R, Ranjan R, Garg S, Garg VK, Sonthalia S, Bansal S. Periorbital hyperpigmentation: a comprehensive review. J Clin Aesthet Dermatol. 2016;9(1):49–55.
Sarkar R, Bhalla M, Kanwar A. A comparative study of 20% azelaic acid cream monotherapy versus a sequential therapy in the treatment of melasma in dark-skinned patients. Dermatology. 2002;205:249–54.
Jegasothy SM, Zabolotniaia V, Bielfeldt S. Efficacy of a new topical nano-hyaluronic acid in humans. J Clin Aesthet Dermatol. 2014;7(3):27–9.
Jones D. Enhanced eyelashes: prescription and over-the-counter options. Aesthet Plast Surg. 2011;35(1):116–21.
Carruthers J, et al. Bimatoprost 0.03% for the treatment of eyebrow hypotrichosis. Dermatol Surg. 2016;42(5):608–17.
Elmets C, Singh D, Tubesing K, Matsui M, Katiyar S, Mukhtar H. Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol. 2001;44(3):425–32.
Wisniewski J, Ellis D, Lupo M. Facial rejuvenation: combining cosmeceuticals with cosmetic procedures. Cutis. 2014;94(3):122–6.
Rokhsar CK, Lee S, Fitzpatrick RE. Review of photorejuvenation: devices, cosmeceuticals, or both? Dermatol Surg. 2005;31(9 Pt 2):1166–78.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Kawa, N., Dabbous, H., Chalhoub, R., Soueidan, N. (2020). Cosmeceuticals for the Periorbital Region. In: Badawi, A. (eds) Periorbital Rejuvenation. Springer, Cham. https://doi.org/10.1007/978-3-030-46866-8_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-46866-8_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-46865-1
Online ISBN: 978-3-030-46866-8
eBook Packages: MedicineMedicine (R0)